Consistent with previous findings that CD133 increases hepatoma cell growth [28, 29], the proliferation rate was 2-3-fold higher in HepG2 cells overexpressing CD133 compared with control cells (Figure 4A and 4B). The gene discussed is PROM1; the disease is hepatocellular carcinoma.